Pages that link to "Q44769788"

The following pages link to Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis (Q44769788):

Displaying 30 items.

• Plant-based solutions for veterinary immunotherapeutics and prophylactics (Q27000876) (← links)
• Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity (Q33912121) (← links)
• Pertussis re-emergence in the post-vaccination era (Q34636630) (← links)
• A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis (Q37384743) (← links)
• Peptide design for antimicrobial and immunomodulatory applications (Q37598400) (← links)
• Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology (Q37833985) (← links)
• Therapeutic strategies based on polymeric microparticles (Q38016146) (← links)
• Animal models for neonatal diseases in humans (Q38067243) (← links)
• Re-emergence of pertussis: what are the solutions? (Q38068231) (← links)
• The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. (Q38068469) (← links)
• Immune modulation by multifaceted cationic host defense (antimicrobial) peptides (Q38162670) (← links)
• Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis. (Q38195758) (← links)
• Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity. (Q38228975) (← links)
• Protecting Newborns Against Pertussis: Treatment and Prevention Strategies. (Q38626455) (← links)
• CD71 erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. (Q38629725) (← links)
• Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens (Q39021470) (← links)
• What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines (Q40295958) (← links)
• Response of immune response genes to adjuvants poly [di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP), CpG oligodeoxynucleotide and emulsigen at intradermal injection site in pigs (Q40642783) (← links)
• Immune responses to Mycoplasma bovis proteins formulated with different adjuvants (Q40703021) (← links)
• Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs (Q43739433) (← links)
• Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin. (Q46008344) (← links)
• Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen™, IDR peptide1002, and poly I:C. (Q47593655) (← links)
• Novel Sperm and Gonadotropin-releasing Hormone-based Recombinant Fusion Protein: Achievement of 100% Contraceptive Efficacy by Co-immunization of Male and Female Mice (Q47980574) (← links)
• Core-shell PLA-PVA porous microparticles as carriers for bacteriocin nisin (Q47997865) (← links)
• The pertussis problem. (Q54406017) (← links)
• Antimicrobial host defence peptides: functions and clinical potential (Q89927176) (← links)
• A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice (Q91440678) (← links)
• Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro (Q92243227) (← links)
• Innate immune response profiles in pigs injected with vaccine adjuvants polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) and Emulsigen (Q92454326) (← links)
• The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies (Q98465739) (← links)